Winslow Evans & Crocker’s Core Laboratories CLB Stock Holding History

Winslow Evans & Crocker’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$3K	Buy	+100	New	+$2.04K	﹤0.01%	1171
2016 Q1	–	Sell	-16	Closed	-$1.63K	–	1299
2015 Q4	$1.63K	Buy	+16	New	+$1.83K	﹤0.01%	1260
2014 Q4	–	Sell	-782	Closed	-$114K	–	1313
2014 Q3	$114K	Sell	782 -400	-34%	-$61.7K	0.03%	400
2014 Q2	$197K	Buy	1,182 +83	+8%	+$14.8K	0.07%	262
2014 Q1	$218K	Sell	1,099 -550	-33%	-$104K	0.08%	254
2013 Q4	$315K	Buy	+1,649	New	+$307K	0.11%	212

Other funds holding CLB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

AKO Capital London, United Kingdom $5.11B AUM 2.56% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Winslow Evans & Crocker's CLB Position: Q4 2020 in Review

Winslow Evans & Crocker opened a new position in Core Laboratories (CLB) in Q4 2020: 100 shares worth $3K. The stake represents ﹤0.01% of the portfolio and ranks #1171 among its holdings. This is a return to the name: Winslow Evans & Crocker previously reported a position in CLB as recently as Q4 2015.

Winslow Evans & Crocker first reported a position in CLB in Q4 2013 and has held it in 6 quarters since. The position peaked at $315K in Q4 2013. 181 funds tracked by Wall St. Rank hold CLB as of Q4 2020.

Winslow Evans & Crocker held 100 shares of Core Laboratories worth $3K as of Q4 2020.
Core Laboratories was a new Winslow Evans & Crocker position in Q4 2020.
Core Laboratories made up ﹤0.01% of Winslow Evans & Crocker's portfolio in Q4 2020, its #1171 holding.
Winslow Evans & Crocker first reported a position in Core Laboratories in Q4 2013 and has held it in 6 quarters since.
Winslow Evans & Crocker's Core Laboratories position peaked at $315K in Q4 2013.
181 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2020.

Based on Winslow Evans & Crocker's 13F filing for Q4 2020, filed 3 Feb 2021.